Teva Pharma Industries Stock Probability of Future Stock Price Finishing Over 17.6
| TEVA Stock | USD 22.21 0.12 0.54% |
Teva |
Teva Pharma Target Price Odds to finish over 17.6
The tendency of Teva Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 17.60 in 90 days |
| 22.21 | 90 days | 17.60 | about 55.37 |
Based on a normal probability distribution, the odds of Teva Pharma to stay above $ 17.60 in 90 days from now is about 55.37 (This Teva Pharma Industries probability density function shows the probability of Teva Stock to fall within a particular range of prices over 90 days) . Probability of Teva Pharma Industries price to stay between $ 17.60 and its current price of $22.21 at the end of the 90-day period is about 55.37 .
Given the investment horizon of 90 days Teva Pharma Industries has a beta of -0.86. This usually implies Additionally Teva Pharma Industries has an alpha of 0.4031, implying that it can generate a 0.4 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Teva Pharma Price Density |
| Price |
Predictive Modules for Teva Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Teva Pharma Industries. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Teva Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Teva Pharma is not an exception. The market had few large corrections towards the Teva Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Teva Pharma Industries, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Teva Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.40 | |
β | Beta against Dow Jones | -0.86 | |
σ | Overall volatility | 1.11 | |
Ir | Information ratio | 0.1 |
Teva Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Teva Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Teva Pharma Industries can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Teva Pharma had very high historical volatility over the last 90 days | |
| Teva Pharma Industries currently holds 20.15 B in liabilities with Debt to Equity (D/E) ratio of 2.27, implying the company greatly relies on financing operations through barrowing. Teva Pharma Industries has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Teva Pharma's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 15.85 B. Net Loss for the year was (615 M) with profit before overhead, payroll, taxes, and interest of 6.97 B. | |
| Teva Pharma has a strong financial position based on the latest SEC filings | |
| About 58.0% of Teva Pharma shares are owned by institutional investors | |
| Latest headline from zacks.com: Pharma Stock Roundup PFEs 2025 Outlook, MRK ABBVs MA Deals |
Teva Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Teva Stock often depends not only on the future outlook of the current and potential Teva Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teva Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 B | |
| Cash And Short Term Investments | 3.2 B |
Teva Pharma Technical Analysis
Teva Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Teva Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Teva Pharma Industries. In general, you should focus on analyzing Teva Stock price patterns and their correlations with different microeconomic environments and drivers.
Teva Pharma Predictive Forecast Models
Teva Pharma's time-series forecasting models is one of many Teva Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Teva Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Teva Pharma Industries
Checking the ongoing alerts about Teva Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Teva Pharma Industries help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Teva Pharma had very high historical volatility over the last 90 days | |
| Teva Pharma Industries currently holds 20.15 B in liabilities with Debt to Equity (D/E) ratio of 2.27, implying the company greatly relies on financing operations through barrowing. Teva Pharma Industries has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Teva Pharma's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 15.85 B. Net Loss for the year was (615 M) with profit before overhead, payroll, taxes, and interest of 6.97 B. | |
| Teva Pharma has a strong financial position based on the latest SEC filings | |
| About 58.0% of Teva Pharma shares are owned by institutional investors | |
| Latest headline from zacks.com: Pharma Stock Roundup PFEs 2025 Outlook, MRK ABBVs MA Deals |
Check out Teva Pharma Backtesting, Teva Pharma Valuation, Teva Pharma Correlation, Teva Pharma Hype Analysis, Teva Pharma Volatility, Teva Pharma History as well as Teva Pharma Performance. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.85) | Revenue Per Share 14.879 | Quarterly Revenue Growth 0.125 | Return On Assets 0.0556 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.